Economics is largely about trade-offs and compromise. Academics study the former but don’t often engage in the latter. In health economics, as in other fields, a key trade-off is between equity and efficiency. We’ve been studying this for a.very.long.time. Despite this, as… Read More »The potential of the super QALY to reconcile the key contentions in health economics
Decision models can be very useful. They can also be very bad. ISPOR and SMDM recently got together to form the Modeling Good Research Practices Task Force and have produced a set of reports. One of the reports, by David… Read More »Call for a model registry
The aim of a health intervention is generally to cause a cost-effective increase to some normative outcome such as by reducing mortality, increasing productivity and so forth. Often policy makers want to encourage or discourage certain behaviours by using incentives… Read More »Cannabis and asbestos: The cost-effectiveness of prohibition as health policy
In economic evaluations in health, time matters. More time in a bad health state is necessarily worse (or no better) than a smaller amount of time in said health state. Likewise, the value of an intervention increases with the duration… Read More »Considering time perception